Printer Friendly

New epilepsy drug is possible. (Biomedicine).

Epilepsy affects more than 2 million people in the United States alone, and existing medications don't always safely control the seizures that mark the disorder. A drug mimicking a natural substance in the brain may offer a new therapy.

In the 1990s, Andrey M. Mazarati of the University of California, Los Angeles and his colleagues found that administering a small protein called galanin arrests epileptic seizures in mice. Galanin is a neuropeptide, a molecule used in small concentrations by the brain's nerve cells.

Galanin itself would make a poor drug, however. It doesn't easily cross from the bloodstream into the brain, which is why Mazarati had to inject the neuropeptide directly into the brain, and it's destroyed quickly by enzymes in the body.

Working with researchers in Sweden, Mazarati has begun testing a synthetic molecule with a structure similar to galanin's. Unlike the neuropeptide, this compound, dubbed galnon, can be injected into the bloodstream and make its way into the brain. It's also resistant to degradation by natural enzymes.

Most important, galnon binds to the same brain-cell-surface proteins, or receptors, that galanin does and prevents seizures. In one widely used mouse model of epilepsy, galnon is actually more effective than diazepam, a common seizure medication. Noting that his Swedish colleagues plan to improve galnon's binding to brain-cell receptors, Mazarati calls the synthetic molecule a prototype for a new class epilepsy drugs. --J.T.
COPYRIGHT 2001 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:use of neuropeptide galanin may help treat condition
Publication:Science News
Article Type:Brief Article
Geographic Code:1USA
Date:Dec 8, 2001
Previous Article:Antibiotic now tackles Parkinson's. (Biomedicine).
Next Article:Thinking the way to stronger muscles. (Biomedicine).

Related Articles
Epilepsy and pregnancy: a drug dilemma.
Mice reveal three epilepsy genes.
GABA receptor linked to absence seizures.
Cost and quality outcomes of comprehensive epilepsy monitoring review of referrals in a managed Medicaid program.
Endgame for Epilepsy?
Shedding light on epilepsy: advocacy groups are pushing to raise awareness about epilepsy and encourage legislatures to make it a more integral part...
Averting pain: epilepsy drug limits migraine attacks.
Potential block for epilepsy: researchers find new drug target.
Brain protein peps up and soothes rodents.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters